Cimetidine, 800 mg at night versus 400 mg twice daily, in the treatment of duodenal ulcer. 1986

L Capurso, and P R Dal Monte, and F Mazzeo, and G Menardo, and A Morettini, and A Saggioro, and G Tafner

A multicentre double-blind study was carried out on a total of 197 patients, to evaluate the safety and efficacy of an 800 mg nighttime dose of cimetidine in comparison with 400 mg twice daily in the treatment of duodenal ulcer. At 4 weeks 84% of the 187 patients eligible for analysis had healed ulcers with the once daily regimen and 68% with the twice daily regimen (p less than 0.05). An early decrease in both day and nighttime pain and in antacid consumption was observed during the first 2 weeks. Adverse effects were few and mild, confirming the safety profile of cimetidine.

UI MeSH Term Description Entries
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004381 Duodenal Ulcer A PEPTIC ULCER located in the DUODENUM. Curling's Ulcer,Curling Ulcer,Curlings Ulcer,Duodenal Ulcers,Ulcer, Curling,Ulcer, Duodenal,Ulcers, Duodenal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L Capurso, and P R Dal Monte, and F Mazzeo, and G Menardo, and A Morettini, and A Saggioro, and G Tafner
August 1986, The British journal of clinical practice,
L Capurso, and P R Dal Monte, and F Mazzeo, and G Menardo, and A Morettini, and A Saggioro, and G Tafner
November 1985, Scandinavian journal of gastroenterology,
L Capurso, and P R Dal Monte, and F Mazzeo, and G Menardo, and A Morettini, and A Saggioro, and G Tafner
July 1984, Deutsche medizinische Wochenschrift (1946),
L Capurso, and P R Dal Monte, and F Mazzeo, and G Menardo, and A Morettini, and A Saggioro, and G Tafner
January 1990, The Journal of international medical research,
L Capurso, and P R Dal Monte, and F Mazzeo, and G Menardo, and A Morettini, and A Saggioro, and G Tafner
July 1981, Medizinische Klinik,
L Capurso, and P R Dal Monte, and F Mazzeo, and G Menardo, and A Morettini, and A Saggioro, and G Tafner
January 1985, G.E.N,
L Capurso, and P R Dal Monte, and F Mazzeo, and G Menardo, and A Morettini, and A Saggioro, and G Tafner
October 1989, Alimentary pharmacology & therapeutics,
L Capurso, and P R Dal Monte, and F Mazzeo, and G Menardo, and A Morettini, and A Saggioro, and G Tafner
January 1985, Current medical research and opinion,
L Capurso, and P R Dal Monte, and F Mazzeo, and G Menardo, and A Morettini, and A Saggioro, and G Tafner
September 1985, The American journal of gastroenterology,
L Capurso, and P R Dal Monte, and F Mazzeo, and G Menardo, and A Morettini, and A Saggioro, and G Tafner
April 1986, Wiener klinische Wochenschrift,
Copied contents to your clipboard!